Greenwich LifeSciences, Inc.
NASDAQ:GLSIBiotechnology
-$0.74 today
- Market cap
- $302.08M
- Beta
- 1.38
- P/E (TTM)
- -15.6
- EPS (TTM)
- -$1.49
Volume 0.71M
Average 0.14M
GLSI Other Non-current Assets
Long-term assets not reported separately.
Greenwich LifeSciences, Inc.NASDAQ: GLSI
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets remains negative
Q1 FY2026 other non-current assets was $0, compared with $0 a year earlier.
Context
- Other non-current assets amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other non-current assets increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 0 | -61.8% |
| FY2021 | 2021-12-31 | 0 | — |
Other Non-current Assets vs competitors
How GLSI compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Other non-current assets amounts to 0.0% of total assets for GLSI, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $4.32M USD | -39.6% | +49.6% | 1.6% | |
| Mar 2026 | $213K USD | -80.6% | — | 0.1% | |
| Mar 2026 | $185.14K USD | +806.8% | +156.9% | 0.2% | |
| Mar 2026 | $34K USD | -66.3% | -66.6% | 0.0% | |
| Mar 2026 | $33.77K USD | — | +594.4% | 0.1% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
IRDOpus Genetics, Inc. | Mar 2026 | $0 USD | — | — | 0.0% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Peer median (excluding GLSI) | — | -53.0% | +103.3% | 0.1% | |
Competitors are the stored peer set for GLSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Greenwich LifeSciences, Inc.
NASDAQ:GLSI
Intrinsic Alpha fair value
Locked
Current Price
$20.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.